Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression

Molecular Psychiatry

Volumn 16, Issue 7, 2011, Pages 751-762

  Shelton, R C ^a   Claiborne, J ^a   Sidoryk Wegrzynowicz, M ^a   Reddy, R ^a   Aschner, M ^a   Lewis, D A ^b   Mirnics, K ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

apoptosis; cytokines; inflammation; major depression; microarray; oxidative stress

Indexed keywords

APOPTOSIS INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; METALLOTHIONEIN 1M; METALLOTHIONEIN I; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; EXON; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; APOPTOSIS; CLUSTER ANALYSIS; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FRONTAL LOBE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STATISTICS AS TOPIC;

EID: 79959611025     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.52     Document Type: Article

References (67)

1. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213: 93-118.
2. Sibille E, Arango V, Galfalvy HC, Pavlidis P, Erraji-Benchekroun L, Ellis SP, et al. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 2004; 29: 351-361. (Pubitemid 38175153)
3. Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 2004; 101: 15506-15511. (Pubitemid 39441571)
4. Sequeira A, Gwadry FG, French-Mullen JM, Canetti L, Gingras Y, Casero Jr RA, et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006; 63: 35-48. (Pubitemid 43037467)
5. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, French-Mullen J, et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2007; 14: 175-189.
6. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653-15658. (Pubitemid 41528111)
7. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005; 10: 309-322. (Pubitemid 40432684)
8. Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, Stockmeier CA, et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci 2007; 27: 13329-13340. (Pubitemid 350220503)
9. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 2008; 60: 184-191.
10. Lewis DA. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 2002; 26: 143-154. (Pubitemid 34093077)
11. Mirnics K, Levitt P, Lewis DA. DNA microarray analysis of postmortem brain tissue. Int Rev Neurobiol 2004; 60: 153-181. (Pubitemid 39753907)
12. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ, et al. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 1999; 19: 9029-9038. (Pubitemid 30226722)
13. Kufahl PR, Li Z, Risinger RC, Rainey CJ, Wu G, Bloom AS, et al. Neural responses to acute cocaine administration in the human brain detected by fMRI. NeuroImage 2005; 28: 904-914. (Pubitemid 41713625)
14. Devous MD, Trivedi MH, Rush AJ. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J Nuclear Med 2001; 42: 535-542. (Pubitemid 32298269)
15. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 2008; 43: 76-87.
16. Pizzagalli DA, Jahn AL, OShea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry 2005; 57: 319-327. (Pubitemid 40215760)
17. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 2008; 60: 184-191.
18. Gaughran F, Payne J, Sedgwick PM, Cotter D, BerryM. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 2006; 70: 221-227. (Pubitemid 44067346)
19. Carroll BJ, Cassidy F, Naftolowitz D, Tatham NE, Wilson WH, Iranmanesh A, et al. Pathophysiology of hypercortisolism in depression. Acta Psychiatrica Scandinavica, Supplementum 2007; 433: 90-103. (Pubitemid 46114844)
20. Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gasto C. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1027-1033. (Pubitemid 46810093)
21. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 2008; 30: 303-311.
22. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2007; 13: 147-161.
23. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005; 120: 701-713. (Pubitemid 40343081)
24. Mirnics K, Pevsner J. Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 2004; 7: 434-439. (Pubitemid 38544572)
25. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nat Genet 2006; 38: 500-501.
26. Campbell DB, DOronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007; 62: 243-250. (Pubitemid 47525400)
27. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. From the cover: gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550. (Pubitemid 41528093)
28. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445. (Pubitemid 37033947)
29. Wang X, Narayanan M, Bruey JM, Rigamonti D, Cattaneo E, Reed JC, et al. Protective role of Cop in Rip2/caspase-1/caspase- 4-mediated HeLa cell death. Biochim Biophys Acta 2006; 1762: 742-754. (Pubitemid 44293374)
30. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22. (Pubitemid 44911890)
31. Wang X, Wang H, Figueroa BE, Zhang WH, Huo C, Guan Y, et al. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntingtons disease. J Neurosci 2005; 25: 11645-11654. (Pubitemid 43098457)
32. Uzonyi B, Lotzer K, Jahn S, Kramer C, Hildner M, Bretschneider E, et al. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc Natl Acad Sci USA 2006; 103: 6326-6331.
33. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003; 25: 691-698. (Pubitemid 36850797)
34. McKernan DP, Dinan TG, Cryan JF. Killing the blues. A role for cellular suicide (apoptosis) in depression and the antidepressant response? Progress Neurobiol 2009; 88: 246-263.
35. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat 2009; 5: 433-449.
36. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851-1861. (Pubitemid 40731764)
37. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1- dependent pathways. Nat Med 2004; 10: 594-601. (Pubitemid 38796850)
38. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31. (Pubitemid 43083561)
39. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Minireview. Neuro Endocrinol Lett 2008; 29: 287-291.
40. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56: 819-824.
41. Capuron L, Gumnick JF,Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002; 26: 643-652. (Pubitemid 34260983)
42. Raison CL, Woolwine BJ, Demetrashvili MF, Borisov AS, Weinreib R, Staab JP, et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 2007; 25: 1163-1174. (Pubitemid 46650303)
43. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999; 20: 370-379. (Pubitemid 29099768)
44. Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 767-780. (Pubitemid 32374966)
45. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 2001; 21: 199-206. (Pubitemid 32221058)
46. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 5: 401-412. (Pubitemid 35470359)
47. OBrien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004; 19: 397-403. (Pubitemid 39172804)
48. Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin 2006; 24: 441-460. (Pubitemid 44108539)
49. Garcia-Bueno B, Caso JR, Leza JC. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev 2008; 32: 1136-1151.
50. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-741.
51. Griffiths M, Neal JW, Gasque P. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. In: Giacinto Bagetta MTCa (ed). International Review of Neurobiology Neuroinflammation in Neuronal Death and Repair, Vol. 82 ed Academic Press: Amsterdam, NL, 2007, pp 29-55.
52. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009; 158: 1021-1029.
53. Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005; 135: 659-678. (Pubitemid 41407732)
54. Bartolomucci A, Palanza P, Parmigiani S, Pederzani T, Merlot E, Neveu PJ, et al. Chronic psychosocial stress down-regulates central cytokines mRNA. Brain Res Bull 2003; 62: 173-178. (Pubitemid 38091705)
55. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009; 158: 1021-1029.
56. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 2005; 280: 15649-15658. (Pubitemid 40616683)
57. Ip WK, Wong CK, Wang CB, Tian YP, Lam CW. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogenactivated protein kinase and nuclear factor kappaB. Immunopharmacol Immunotoxicol 2005; 27: 371-393. (Pubitemid 41428832)
58. Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006; 31: 2121-2131. (Pubitemid 44413189)
59. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47: 411-418. (Pubitemid 20161259)
60. Chung RS, Leung YK, Butler CW, Chen Y, Eaton ED, Pankhurst MW, et al. Metallothionein treatment attenuates microglial activation and expression of neurotoxic quinolinic acid following traumatic brain injury. Neurotox Res 2009; 15: 381-389.
61. Formigari A, Irato P, Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol 2007; 146: 443-459. (Pubitemid 47494685)
62. Krezel A, Hao Q, Maret W. The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch Biochem Biophys 2007; 463: 188-200. (Pubitemid 47030334)
63. Kumari MVR, Hiramatsu M, Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic Res 1998; 29: 93-101. (Pubitemid 28451388)
64. Sequeira A, Klempan T, Canetti L, ffrench-Mullen J, Benkelfat C, Rouleau GA, et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007; 12: 640-655. (Pubitemid 46998251)
65. Leventhal AM, Rehm LP. The empirical status of melancholia: implications for psychology. Clin Psychol Rev 2005; 25: 25-44. (Pubitemid 41556532)
66. Parker G, Hadzi-Pavlovic D, Austin MP, Mitchell P, Wilhelm K, Hickie I, et al. Sub-typing depression, I. Is psychomotor disturbance necessary and sufficient to the definition of melancholia? Psychol Med 1995; 25: 815-823.
67. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H. Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001; 251: 90-97. (Pubitemid 32488037)